Motoki Fukutomi

Impact of Preoperative Diuretics Treatment on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Implantation

Shun Hirosawa, Hiroaki Yokoyama, Ken Yamazaki, Shun Shikanai et autres

Diuretics are used to relieve congestive symptoms in patients with severe aortic stenosis (AS). However, the effect of preprocedural diuretic treatment on long-term outcomes in AS patients who undergoing transcatheter aortic valve implantation (TAVI) remains unclear. We prospectively enrolled 4,903 consecutive AS …

jp (code pays fourni par la source)

Outcomes of Hemodialysis Patients Undergoing Contemporary Transcatheter Aortic Valve Implantation ― Insights From the LAPLACE-TAVI Registry ―

Ryosuke Higuchi, Shuro Narui, Itaru Takamisawa, Mamoru Nanasato et autres

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an alternative to surgical aortic valve replacement in hemodialysis patients; however, contemporary outcomes and risk stratifications remain unreported. METHODS AND RESULTS: Using data from a multicenter database, this study included 2,888 patients who underwent TAVI …

jp (code pays fourni par la source)

Prognostic factors and outcomes in patients under 75 years old receiving transcatheter aortic valve implantation: insights from the LAPLACE registry

Ryotaro Matsuo, S Doi, N Takahashi, H Iwata et autres

Abstract Background Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. However, from the perspective of prosthetic valve durability, surgical aortic valve replacement (SAVR) is often prioritized in younger patients. The ESC/EACTS Guidelines for the management of valvular …

jp (code pays fourni par la source)

Early clinical and hemodynamic comparison of the latest-generation Evolut FX and SAPIEN 3 Ultra RESILIA Valves in transcatheter aortic valve implantation

N Takahashi, S Doi, Ryotaro Matsuo, H Iwata et autres

Abstract Backgrounds Transcatheter aortic valve implantation (TAVI) is a well-established treatment for severe aortic stenosis, with continuous advancements in valve technology aimed at improving clinical outcomes. However, real-world data comparing the latest-generation Evolut FX and SAPIEN 3 Ultra RESILIA (S3 UR) valves …

jp (code pays fourni par la source)

Prognostic predictors after TAVI in patients with severe aortic stenosis and concomitant aortic regurgitation

N Takahashi, S Doi, Ryotaro Matsuo, H Iwata et autres

Abstract Backgrounds Transcatheter aortic valve implantation (TAVI) has become an established treatment for aortic stenosis (AS). However, in patients with concomitant aortic regurgitation (AR), the hemodynamic changes and clinical outcomes following TAVI may differ from those in patients without AR. The clinical …

jp (code pays fourni par la source)

Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis

Daniele Giacoppo, Hector A. Alvarez‐Covarrubias, Erion Xhepa, Yuji Matsuda et autres

BACKGROUND: Differences between balloon- and self-expandable transcatheter heart valves (BE-THVs and SE-THVs, respectively) may influence the outcomes of transcatheter aortic valve replacement for bicuspid aortic valve (BAV) stenosis. METHODS: Consecutive patients undergoing transcatheter aortic valve replacement with BE-THV or SE-THV for computed …

ie, it, au, de, mx, jp, ch, us, dk, fr, ca, nl, il, gb (code pays fourni par la source)

Scoring of cardiac damage evaluated by echocardiography predicts prognosis of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: analysis of the LAPLACE–TAVI registry

Shunsuke Edamura, Harutoshi Tamura, Tetsu Watanabe, Takayuki Sugai et autres

jp (code pays fourni par la source)

Efficacy of a 16 Fr sheath strategy during Impella support to reduce access site bleeding in patients with cardiogenic shock

Motoki Fukutomi, Takayuki Onishi, Tomo Ando, Shuichiro Takanashi et autres

jp (code pays fourni par la source)

Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new‐generation devices: Insights from the LAPLACE‐TAVI registry

Motoki Fukutomi, Takayuki Onishi, Tomo Ando, Ryosuke Higuchi et autres

BACKGROUND: A history of hospitalization for heart failure (HHF) before transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement is associated with the prognosis of patients with severe aortic stenosis (AS). However, the impact of prior HHF on clinical outcomes after …

jp (code pays fourni par la source)

Two-stage hybrid strategy for multivessel coronary artery disease and functional ischemic mitral regurgitation: A case series

Motoki Fukutomi, Kenji Wada, Tomoya Uchimuro, Mizuho Hoshina et autres

jp (code pays fourni par la source)

Ipsilateral snare technique for the safe delivery of the Evolut PRO transcatheter aortic valve system: a case report

Motoki Fukutomi, Takayuki Onishi, Tomo Ando, Tetsuya Tobaru

Background: Transcatheter aortic valve implantation (TAVI) requires several bail-out techniques for safe valve delivery and deployment. Particularly in cases of challenging aortic anatomy, the snare technique from the contralateral side of the surgical site can facilitate delivery of the transcatheter heart valve …

jp (code pays fourni par la source)

Procedural Volume and Outcomes of Transfemoral Transcatheter Aortic Valve Replacement: From a Japanese Nationwide Registry

Tomo Ando, Hiraku Kumamaru, Shun Kohsaka, Motoki Fukutomi et autres

jp (code pays fourni par la source)